Testing GLP-1 Drugs for Substance Use Disorders
Limited human trials of GLP-1 drugs for substance use disorders indicate they might not work well for non-obese individuals.
Balance Is Key
Potential miracle is that GLP-1 drugs ease withdrawal symptoms. Even setting aside the illegal addictive substances and considering only nicotine and alcohol, it would seem like a golden opportunity.
A New Book Makes The Case That Addiction Is Not a Brain Disease
A new book and a new brain study are raising doubts about addiction as a chronic brain condition.
Does Ozempic Cause Weight Loss By Making People Sick?
We examine anecdotal reports and scientific evidence concerning gastrointestinal discomfort as a result of taking GLP-1 drugs.
Advances in Epigenetic Editing for Addiction Treatment
Crispr and other technologies are allowing researchers to turn on and off genetic and cellular switches impacting addictive behavior.
The Anticipation Wrinkle
Today, dopamine seems to be universally regarded as “the reward.” But the dopamine/eating link is also a two-way street.